• State of Stanford Medicine on Sept. 17

    Stanford Medicine’s leadership will address a variety of topics and discuss the future of the School of Medicine and hospitals.

  • Rally to raise awareness scheduled

    After a statement about guns ended prospects for a government appointment, a Stanford professor joined a student in forming a nonprofit to address the public health issue.

  • Same mutations fuel cancer metastases

    The true driver mutations of cancer are almost always common to all metastases in an individual, according to a Stanford scientist and other researchers.

  • Predicting aneurysm risk from DNA

    By combining genome-sequence information and health records, Stanford scientists have developed a new algorithm that can predict the risk of abdominal aortic aneurysm, and potentially could be used for any number of diseases.

  • Weather predicts incidence of snakebites

    Rattlesnake bites, contrary to public opinion, increase after periods of high rainfall, not drought, according to a Stanford-led study that examined 20 years of snakebite history in California.

  • What to know about concussions

    Angela Lumba-Brown, MD, co-director of the Stanford Concussion and Brain Performance Center, is the lead author of the newly published CDC Guidelines on the Management of Mild Traumatic Brain Injury in Children. In a recent interview, she explained what families should know about concussions.

  • Safer gene therapy?

    A new study gives Stanford researchers hope that they may have solved a big problem plaguing gene therapy: the prospect of an autoimmune attack.

  • Toll of armed conflict in Africa

    A Stanford-led analysis of the indirect impact of armed conflict in Africa shows that as many as 3.5 million infants born within 30 miles of combat were killed over two decades.

  • Ketamine tied to opioid system

    Ketamine’s antidepressive effects require activation of opioid receptors in the brain, a new Stanford study shows. The surprising finding may alter how new antidepressants are developed and administered in order to mitigate the risk of opioid dependence.

  • John Farquhar dies at 91

    John Farquhar, a beloved mentor, pioneer in cardiovascular disease prevention and professor emeritus of medicine and of health research and policy at Stanford, died Aug. 22 at the age of 91.